<DOC>
	<DOC>NCT02196519</DOC>
	<brief_summary>A first in human study evaluating the safety of Sylys Surgical Sealant in protecting the anastomotic junction created during a stoma reversal procedure.</brief_summary>
	<brief_title>Clinical Evaluation of Cohera Sylys Surgical Sealant as an Adjunct to Standard Bowel Anastomosis Closure</brief_title>
	<detailed_description />
	<criteria>Be at least 18 years of age Be in good general health in the opinion of the investigator with no conditions that would significantly impact wound healing as determined by medical history and review of recent concomitant medications Be scheduled for an ileostomy reversal procedure Be willing to follow instructions for incision care Agree to return for all followup evaluations specified in this protocol Sign informed consent Anesthesia risk judged to be higher than ASA2 Have severe comorbid conditions that pose a high risk for surgery and adequate recovery (e.g., heart disease) Any condition involving compromised immune system Any condition known to effect wound healing, such as collagen vascular disease Known blood clotting disorder Be receiving antibiotic therapy for preexisting condition or infection Concurrent use of fibrin sealants or other anastomosis care devices Be currently taking systemic steroids or immunosuppressive agents Have known or suspected allergy or sensitivity to any test materials or reagents Be participating in any current clinical trial or have participated in any clinical trial within 30 days of enrollment in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>